ModivCare Inc

ModivCare — Q4 2020 Earnings Presentation

11 slides from ModivCare's earnings presentation, Feb 26, 2021

  1. Slide 1: ModivCare Q4 2020 Earnings Presentation

    MODIVCARE INC. February 26, 2021 NASDAQ: MODV Q4 2020 EARNINGS PRESENTATION

  2. Slide 2: Forward Looking Statements

    FORWARD LOOKING STATEMENTS MODIVCARE INC. // 2 Certain statements contained in this presentation constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are predictive in nature and are frequently identified by the use of t

  3. Slide 3: Today's Agenda

    TODAY’S AGENDA MODIVCARE INC. // 3 • Opening Remarks – Dan Greenleaf, President and Chief Executive Officer ‒ Recap of Q4 and accomplishments in 2020 o Sharpened focus on the Social Determinants of Health o Upgraded senior leadership team and supporting talent o Acted on the voice of the customer o

  4. Slide 4: Q4 2020 Financial Summary

    Q4 2020 FINANCIAL SUMMARY MODIVCARE INC. // 4 $384.8 $398.5 Q4 2019 Q4 2020 Revenue ($ mm) $10.2 $41.6 Q4 2019 Q4 2020 Adjusted EBITDA1 ($ mm) 1 See appendix for a reconciliation of non-GAAP financial measures. • Revenue benefited from the National MedTrans acquisition, higher membership and the Sim

  5. Slide 5: Matrix Investment

    $6.3 $16.3 Q4 2019 Q4 2020 $64.6 $121.9 Q4 2019 Q4 2020 MATRIX INVESTMENT MODIVCARE INC. // 5 Revenue1 ($ mm) Adjusted EBITDA1,2 ($ mm) 1 ModivCare’s interest in Matrix is accounted for as an equity method investment. Matrix’s results are not included within ModivCare’s consolidated financials. 2 Se

  6. Slide 6: Cash Flow Update

    CASH FLOW UPDATE MODIVCARE INC. // 6 Cash flow • Collections related to profit corridor and reconciliation contracts in Q4 2020 resulted in working capital pick up of $42mm that may be refunded at some point in the future • Paid down $75mm revolver balance • No outstanding revolver debt at 12/31 $Mi

  7. Slide 7: Balance Sheet Update

    BALANCE SHEET UPDATE MODIVCARE INC. // 7Prior to Q3 2020, shares outstanding equals common shares outstanding plus total preferred shares on an as-converted basis. $Millions Q4 2019 Q1 2020 Q2 2020 Q3 2020 Q4 2020 Cash 61.4$ 254.4$ 41.8$ 183.3$ 183.3$ Debt - 162.0 - - 486.0 Net Cash / (Debt) 61.4$ 9

  8. Slide 8: Appendix

    APPENDIX MODIVCARE INC. // 8

  9. Slide 9: Adjusted EBITDA Reconciliation (Continuing Operations)

    ADJUSTED EBITDA RECONCILIATION (CONTINUING OPERATIONS) MODIVCARE INC. // 9 $Millions Q4 2020 Q4 2019 Full Year 2020 Full Year 2019 Revenue 398.5$ 384.8$ 1,368.7$ 1,509.9$ (Loss) Income from Cont Ops (2.9) (11.4) 71.9 (5.0) Interest Expense, Net 15.5 0.1 17.6 0.9 Income Tax Provision (Benefit) 5.0 (4

  10. Slide 10: Adjusted EBITDA Reconciliation (Matrix)

    ADJUSTED EBITDA RECONCILIATION (MATRIX) MODIVCARE INC. // 10 The results of our equity method investment are excluded from the calculation of ModivCare's Adjusted EBITDA and Adjusted Net Income. $Millions Q4 2020 Q4 2019 Full Year 2020 Full Year 2019 Revenue 121.9$ 64.6$ 414.6$ 275.4$ Net (Loss ) In

  11. Slide 11: Matrix – Illustrative Valuation

    MATRIX – ILLUSTRATIVE VALUATION DIFFERENT CAPITAL STRUCTURE THAN MODIVCARE MODIVCARE INC. // 11 • Legacy risk adjustment models consistently trade at EBITDA multiples of 10x-12x • New risk- and value-based models similar to Matrix are obtaining EBITDA multiples greater than 12x $Millions Illustrativ

ModivCare — Q4 2020 Earnings Presentation on 6ix